Loading...
 

Volume 34, Issue 4, December 2023



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(3):391-5
Tonic-Clonic Seizure in Patient With SLE: Posterior Reversible Encephalopathy Syndrome, or a Neuropsychiatric Manifestation of SLE?
Authors Information

1Nephrology Department, Meram School of Medicine, Necmettin Erbakan University, Turkey

2Internal Medicine Department, Meram School of Medicine, Necmettin Erbakan University, Turkey

Y Ozturk, N Ozturk, A Argun, H Ozer, F Yonet, İ Baloglu 

Abstract
Posterior reversible encephalopathy syndrome (PRES) is a clinically and radiologically diagnosed reversible sudden onset disease with many neurological symptoms. SLE is the most common cause of PRES among autoimmune diseases. Many factors, such as SLE activity, hypertension, hematological and renal diseases, lymphopenia dyslipidemia, and immunosuppressive treatments, can trigger PRES in SLE. We wanted to draw attention to the difference between neuropsychiatric systemic lupus erythematosus (SLE) and PRES in a patient with SLE and the triggers for developing PRES in SLE by presenting a hypertensive patient on immunosuppressive therapy who had just started haemodialysis treatment and had generalised tonic-clonic seizures.


Cite this article as: Ozturk Y, Ozturk N, Argun A, Ozer H, Yonet F, Baloglu I. Tonic-Clonic Seizure in Patient With SLE: Posterior Reversible Encephalopathy Syndrome, or a Neuropsychiatric Manifestation of SLE? Mediterr J Rheumatol 2023;34(3):391-5.

 

Article Submitted: 16 Nov 2022; Revised Form: 31 Mar 2023; Article Accepted: 15 May 2023; Available Online: 5 Sep 2023

https://doi.org/10.31138/mjr.20230905.tc

This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).